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Abstract
Background: Prior to the 1990s, P. multocida capsular serogroup A was the most prevalent in China, followed by
serogroups B and D. Thirty years later, serogroup D became the most prevalent, followed by serogroups A and B.
However, the P. multocida capsular serogroups currently circulating in China remain unclear. Therefore, the aim of
the present study was to provide an update on P. multocida serogroups isolated from diagnostic samples collected
from clinically diseased pigs in Central and Eastern China from 2011 to 2015.
Results: Between February 2011 and October 2015, 296 isolates of Pasteurella multocida were collected from 3212
pigs with clinical respiratory disease in 12 provinces of China (isolation rate of 9.2%). Of the 296 collected isolates,
146 (49.3%) were P. multocida capsular type A, 141 (47.6%) were capsular type D, and one was capsular type B.
Streptococcus suis (94/193; 48.7%), Haemophilus parasuis (76/193; 39.3%), Escherichia coli (53/193; 27.5%), and
Bordetella bronchiseptica (26/193; 13.5%) were frequently isolated together with P. multocida. A total of 14
toxigenic P. multocida strains co-isolated with other pathogens from 32 cases of atrophic rhinitis were classified
into serogroup D. The virulence of P. multocida capsular type A isolates was higher than that of capsular type D
isolates based on LD50 studies in mice.
Conclusions: Over the past 5 years, P. multocida capsular type A was the most frequently isolated from diagnostic
submissions in Central and Eastern China, followed by serogroups D and B.
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Background
Pasteurella multocida (P. multocida), a Gram-negative,
non-motile, facultative coccobacillus, belonging to the
Pasteurellaceae family [1], is an opportunistic pathogen
and common inhabitant of the upper respiratory tract of
many animal species, and a causative agent of numerous
economically important diseases worldwide, including
atrophic rhinitis (AR) in swine, fowl cholera in birds,
pneumonia and shipping fever in cattle, snuffles in rabbits
[2–4], and occasional zoonotic infections in humans [5].
P. multocida strains are classified into five capsular
serogroups (A, B, D, E, and F) and 16 somatic serotypes
(1 to 16) based on lipopolysaccharide antigens [6–8]. To
date, capsular serogroups A, B, and D have been identified
in pigs [8, 9]. Of these, serogroups A and D are causative
agents of AR, which result in significant economic losses
to the swine industry worldwide [9–12].
P. multocida possesses various virulence factors, includ-
ing fimbriae, adhesins, and toxins, especially dermonecrotic
toxin. Of these virulence factors, toxins produced by
serogroups A and D play important roles in the patho-
genicity of P. multocida. Only toxigenic strains can
cause AR, which is characterized by loss of the nasal
turbinate bone [13, 14]. Therefore, data on P. multocida
toxins can provide better understanding of pasteurellosis
in pigs.
Diseases caused by different serogroups and their preva-
lence may change over time within particular regions. Prior
to the 1990s, capsular serogroups A and B were the most
prevalent in diseased pigs in China, followed by serogroup
D [15]. Thirty years later, serogroups A and D became the
most prevalent, followed by serogroup B [8]. However,
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these data are from several years ago and do not repre-
sent P. multocida capsular serogroups circulating in
China in recent years, as the identification of P. multocida
capsular serogroups currently circulating in China remain
unclear. Hence, to provide an update on P. multocida
capsular serogroups currently circulating in China, we
investigated a total of 296 P. multocida strains isolated
from pigs submitted to our diagnostic laboratory from
12 provinces of China from 2011 to 2015 to estimate
the occurrence of P. multocida alone and in combination
with other bacterial pathogens in pigs with respiratory
disease. The findings of this study provide useful data
to inform control strategies for respiratory disease and




Between February 2011 and October 2015, a total of
3212 lung samples were collected from pigs submitted
to our diagnostic laboratory from 12 different provinces
in Central and Eastern China for further identification of
P. multocida. The data obtained from clinically affected
pigs in Central and Eastern China may reflect, at least in
part, the true occurrence of P. multocida in diagnostic
submissions from the whole of China, since most of the
pigs were raised in Central and Eastern China. All lung
samples exhibited different degrees of pneumonic lesions
and were collected by a single skilled veterinarian.
A total of 713 commercial pig farms were included,
which had a wide variety of management types and herd
size with small-, medium- and large-scale pig farms as
well as various types of backyard farms. Only one pig
farm was selected per region. If there was more than
one pig farm in the same region, the larger pig farm was
selected. During the study period, 13 to 107 pig cases
were collected per month. One to 10 lung samples were
randomly collected per herd. If more than one P. multocida
isolate was found in the same herd, one of the isolates
belonging the same serogroup was included in the analysis.
All samples were processed for bacterial culture within
10 h of collection.
Bacterial isolation and identification
Each sample was plated on tryptic soy agar supplemented
with 10 μg/mL of nicotinamide adenine dinucleotide and
5% fetal calf serum. All plates were incubated at 37 °C for
24–48 h. Afterward, the isolates were purified and cultured
by standard methods for rapid primary identification of P.
multocida, Streptococcus suis (S. suis), Haemophilus
parasuis (HPS), Escherichia coli (E. coli), Bordetella
bronchiseptica (Bb), and Salmonella spp., respectively,
by polymerase chain reaction (PCR) using the respective
specific primers listed in Table 1, as described previously
[16–21]. After this stage, the strains were further identified
by Gram-staining characteristics and oxidase (Gram-
negative bacilli) or catalase tests [22]. All primers were
synthesized by Sangon Biotech Co., Ltd. (Shanghai,
China). Standard P. multocida, E. coli, and Salmonella
strains, purchased from China Institute of Veterinary
Drug Control (Beijing, China), and Bb and HPS strains,
stored at our laboratory [23], were used as positive con-
trols. Sterile water was used as a negative control. All
isolates were freeze-dried and stored at –80 °C.
Capsule typing
The capsular types of P. multocida were confirmed by
multiplex capsule PCR with capsule-specific primer pairs
(Table 1), as described by Townsend et al. [7].
Detection of toxA gene
The toxA gene of P. multocida was confirmed by PCR
with a specific primer pair (Table 1), as described by
Zhao et al. [24].
Detection of virulence
Twenty-five BALB/c mice at 6 weeks of age (Vital River
Laboratories Co., Ltd., Beijing, China) were randomly
assigned to five groups (A1–A5) of five animals each, as
previously described [25]. The mice were housed in a
standard animal facility with ad libitum access to normal
rodent diet and water. P. multocida was cultured on
trypticase soy broth supplemented with 5% fetal calf
serum and incubated on a shaking table at 200 rpm and
temperature of 37 °C for 12–16 h. The number of P.
multocida were enumerated by plate counts. Cultures
were serially diluted 5-fold in sterile phosphate buffered
saline (PBS). Then, the original cultures (undiluted), cul-
tures diluted 5-fold, cultures diluted 25-fold, and cultures
diluted 125-fold were generated. The mice in groups
A1–A4 were inoculated intraperitoneally with 0.2 ml
per mouse of the original cultures, and cultures diluted
5, 25, and 125-fold, respectively, and the mice in group
A5 were injected with 0.2 ml of sterile PBS, as a control
group. The 50% lethal dose (LD50) was calculated on
15 days post-infection, as previously described [25].
Statistical analysis
Statistical analysis was performed using SPSS version 17.0
software (SPSS Inc., Chicago, IL, USA). A p-value <0.05
was considered statistically significant.
Results
Prevalence of P. multocida in porcine clinical samples
Over the 5-year period of this study, P. multocida was
isolated from 296/3212 (9.2%) lung samples collected
from pigs with clinical respiratory disease. The annual
isolation rates ranged from 7.5% to 10.7% with the
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highest isolation rate recorded in 2012 and the lowest
in 2011 (Table 2). Differences in the isolation rates
were not significant (p > 0.05) between February 2011
and October 2015. There was no association between
collection month and isolation rate (p > 0.05). The
monthly isolation rates ranged from 7.4% to 11.8%
with the highest recorded in month 12, followed by
months 6, 11, and 9 (Fig. 1). In addition, strains of P.
multocida were isolated throughout the year without
seasonal variation (p > 0.05; spring, months 3–5; sum-
mer, months 6–8; autumn, months 9–11; winter,
months 12–2; Fig. 1).
Table 1 Primers used for the identification of bacterial isolates, capsule typing, and the toxA gene
Strains Target genes Name Sequences (5’→ 3’) Product (bp) References
P. multocida kmt1 Pm-1 ATCCGCTATTTACCCAGTGG 457 [17]
Pm-2 GCTGTAAACGAACTCGCCAC
P. multocida (serotype A) hyaD-hyaC APm-1 GATGCCAAAATCGCAGTCAG 1048 [7]
APm-2 TGTTGCCATCATTGTCAGTG
P. multocida (serotype B) dcbD BPm-1 CATTTATCCAAGCTCCACC 758 [7]
BPm-2 GCCCGAGAGTTTCAATCC
P. multocida (serotype D) dcbF DPm-1 TTACAAAAGAAAGACTAGGAGCCC 647 [7]
DPm-2 CATCTACCCACTCAACCATATCAG
P. multocida (serotype E) ecbJ EPm-1 TCCGCAGAAAATTATTGACTC 512 [7]
EPm-2 GCTTGCTGCTTGATTTTGTC
P. multocida (serotype F) fcbD FPm-1 AATCGGAGAACGCAGAAATCAG 852 [7]
FPm-2 TTCCGCCGTCAATTACTCTG
P. multocida (toxA gene) toxA toxA-1 CTTAGATGAGCGACAAGG 864 [24]
toxA-2 GAATGCCACACCTCTATAG
S. suis gdh Ss-1 GCAGCGTATTCTGTCAAACG 689 [20]
Ss-2 CCATGGACAGATAAAGATGG
HPS 16S rRNA HPS-1 TATCGRGAGATGAAAGAC 1086/1090 [21]
HPS-1’ GTAATGTCTAAGGACTAG
HPS-2 CCTCGCGGCTTCGTC
E. coli uidA Ec-1 ATGAAAGCTGGCTACAGGAAGGCC 264 [16]
Ec-2 GGTTTATGCAGCAACGAGACGTCA
Bb flaB Bb-1 TGGCGCCTGCCCTATC 237 [19]
Bb-2 AGGCTCCCAAGAGAGAAA
Salmonella invA Sal-1 CAGGATACCTATAGTGCTGC 580 [18]
Sal-2 CGCACCGTCAAAGGAACCGT
S. suis, HPS, E. coli, and Bb represent Streptococcus suis, Haemophilus parasuis, Escherichia coli and Bordetella bronchiseptica, respectively
Table 2 Numbers of isolates of P. multocida and other pathogens detected in 3212 lung samples from pigs collected between February







Pathogens co-infected with P. multocida
S.suis HPS E. coli Bb Salmonella Others
2011 616 46 7.5 15 13 8 3 2 2
2012 570 61 10.7 20 17 11 4 2 4
2013 630 57 9.0 19 15 11 6 1 3
2014 754 72 9.6 22 17 12 7 3 6
2015 642 60 9.3 18 14 11 6 2 4
Total 3212 296 9.2 94 76 53 26 10 19
(48.7%) (39.3%) (27.5%) (13.5%) (5.1%) (9.8%)
aThere were no significant differences in the annual isolates rates of P. multocida between 2011 and 2015 (p > 0.05). Statistical analysis was performed using the χ2
test. S. suis, HPS, E. coli, and Bb represent Streptococcus suis, Haemophilus parasuis, Escherichia coli and Bordetella bronchiseptica, respectively
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P. multocida strains of capsular type A were isolated
from 146 lung samples (49.3%), capsular type D strains
were isolated from 141 lung samples (47.6%), capsular
type B strains were isolated from one lung sample, and
eight isolates were untypeable. Capsular types E and F
were not detected in this study.
Prevalence of P. multocida accompanied by other species
P. multocida was isolated together with other bacterial
pathogens in 65.2% (193/296) of the lung samples (Table 2).
S. suis (94; 48.7%), HPS (76; 39.3%), and E. coli (53; 27.5%)
were most frequently isolated together with P. multocida,
followed by Bb (26; 13.5%) and Salmonella spp. (10; 5.1%).
S. suis was isolated from 25.3% (812/3212) of the lung sam-
ples, HPS was isolated from 16.6% (533/3212), E. coli was
isolated from 12.9% (415/3212), Bb was isolated from 7.3%
(236/3212), and Salmonella was isolated from 3.3% (107/
3212). P. multocida was the fourth most frequently isolated
bacteria after S. suis, HPS and E. coli.
Prevalence of toxigenic P. multocida accompanied by
other species
Of the 296 P. multocida isolates, only 14 toxigenic strains
of P. multocida were identified by PCR and all were classi-
fied as capsular type D. Over the 5-year period of this
study, 32/3212 (1%) pigs with typical clinical signs of AR
were identified. All toxigenic strains of P. multocida were
isolated from pigs with clinical signs of AR. Ten of these
toxigenic P. multocida strains were isolated with Bb, seven
with HPS, three with S. suis, and one with E. coli. In
addition, Bb was isolated from pigs with no infection of
toxigenic P. multocida strains.
Virulence
Twenty strains of P. multocida of each capsular types A
and D were randomly selected, respectively, to estimate
the LD50 in mice. Twenty-five mice were used for each
of these 40 isolates (1000 mice in total). The results showed
that the virulence of only one isolate of P. multocida capsu-
lar type A was relatively weak with a LD50 of 2.1 × 10
5, and
the virulence of PM-30 of P. multocida capsular type D
strain was lowest with a LD50 of > 4.9 × 10
7. As a whole, the
virulence of P. multocida capsular type A was higher than
that of capsular type D (Table 3).
Discussion
In China, as in other parts of the world, P. multocida is
frequently associated with outbreaks of respiratory infec-
tions in pigs. In this study, the prevalence of P. multocida
infection was 9.2% (296/3212), which was higher (p > 0.05,
χ2 test) than in previous reports (8.0%, 233/2912) from
China [8]. Additionally, the χ2 test results showed that the
annual prevalence of P. multocida infection was relatively
stable (p > 0.05) between 2011 and 2015, in accordance
with the annual prevalence from 2003 to 2007, as reported
by Tang et al. [8]. The results of this study showed that
the prevalence of P. multocida infection did not signifi-
cantly differ (p > 0.05) by season, in agreement with the re-
port by Tang et al. [8]. In addition, there was no clear
association of P. multocida infection with the sampling
month, with the highest prevalence in month 12, followed
by month 6. However, because only a few samples fron
each month were assayed, the data in this study may not
reflect the real differences between months. Hence, the
difference in isolation rates between months should to be
addressed in future studies.
Our findings suggest that strains of P. multocida are
widely prevalent on pig farms, and there were no differ-
ences in the prevalence (p > 0.05, χ2 test) of P. multocida
of capsular type A (49.3%) and D (47.6%), which was dif-
ferent from the results of previous report from China
(39.5% vs. 54.9%, p < 0.05) [8] and different from the re-
port by Rajkhowa et al. [26]. These results showed that
the prevalence of P. multocida capsular type A strains
exhibited a tendency to increase over the past 5 years in
China. The reasons for this tendency were unclear and
need to be addressed in future studies. The eight untype-
able isolates, which were associated with pneumonic
pasteurellosis, should be further investigated.
In this study, S. suis, HPS, E. coli, and Bb were frequently
isolated together with P. multocida. Similar results were re-
ported by Tang et al. [8] and Zhao et al. [22]. Accumulating
evidence suggests that mixed infection of two or more bac-
teria may have been common over the last decade in China.
Therefore, the practical significance of this finding is that
future work on control of disease caused by P. multocida in
pigs may require investigation of multivalent vaccines based
Fig. 1 Distribution of P. multocida isolates by the sampling month
between February 2011 and October 2015. The isolation rates were
19/222, 20/253, 22/296, 25/297, 21/233, 38/332, 28/303, 24/280, 21/
217, 21/260, 29/281, and 28/238 for months 1–12, respectively. The
isolation rates given are the average isolation rates per month over
the 5-years study period. The highest isolation rates were recorded
in month 12, followed by months 6, 11, and 9. However, as a whole,
differences in the isolation rates were not significant (p> 0.05). Statistical
analysis was performed using the χ2 test
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on these bacteria rather than a monovalent vaccine.
In addition, our results showed high isolation rates
of S. suis, HPS, E. coli, and Bb, in accordance with
recent reports from China [8, 22] and some other
countries [27–29].
AR is seldom reported in China, which is supported
by our findings (32/3212) as well as the reports by Tang
et al. [8] and Zhao et al. [22]. The findings of previous
studies combined with those of the present study con-
firmed the presence of AR in Henan, Shandong, Fujian,
Hainan, Anhui, and Hubei provinces to date. In this
study, all 14 toxigenic P. multocida strains were type D,
which was in accordance with the findings of previous
reports [8, 9, 22, 30]. In addition, 14 toxigenic P. multocida
strains were isolated together with one, two, or three other
pathogens and Bb was most frequently isolated with
toxigenic P. multocida.
Previous reports have mainly focused on the detec-
tion of virulence genes of P. multocida isolates. This is
the first large-scale study of the virulence of P. multo-
cida isolates based on LD50 studies in mice. Our find-
ings showed that the virulence of P. multocida capsular
type A isolates was higher than that of capsular type D
isolates. The high virulence and prevalence of isolates
of P. multocida capsular type A is expected to increase
economic losses to the swine industry in China.
Conclusions
Our results disclosed epidemiological information of P.
multocida infection of pigs over the past 5 years in
China. Data from a total of 296 P. multocida isolates re-
vealed no significant difference in the prevalence of P.
multocida capsular types A and D in diagnostic procine
lung samples submitted from 12 provinces in Central
and Eastern China, and S. suis, HPS, E. coli, and Bb are
often isolated together with P. multocida. In addition,
our results showed that the virulence of P. multocida
capsular type A was greater than that of capsular type D.
The findings of this study are expected to facilitate a better
understanding of the current status of P. multocida infec-
tion among pigs in China.
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